Genomtec S.A.

Research Genomtec S.A. (GMT) on Bullrun: market cap PLN 70.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGMT
• ExchangeWAR
• CountryPoland
• SectorHealthcare
• IndustryMedical Devices
• CurrencyPLN
• Market capPLN 70.80M
• Financial periodQ3 2025
• RevenuePLN 4.00K
• Net income-PLN 2.57M
• Free cash flow-PLN 2.22M
• Gross margin-143250.0%

Valuation Snapshot

latest market cap is PLN 70.80M.

About Genomtec S.A.

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysis of biological material of patients using swabs, urine, and saliva.

Frequently asked questions

What is Genomtec S.A.'s market cap?

Genomtec S.A.'s market capitalization is PLN 70.80M.

What does Genomtec S.A. do?

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.